Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.
Daniel Dindo, Nicolas Demartines, Pierre-Alain Clavien
https://pubmed.ncbi.nlm.nih.gov/15273542/Actively Recruiting
Led by Larissa University Hospital · Updated on 2025-09-04
44
Participants Needed
1
Research Sites
52 weeks
Total Duration
Researchers are evaluating the improvement of anorectal and urogenital urinary function as well as postoperative quality of life in patients undergoing Total Mesorectal Excision TME for rectal cancer. The study focuses on the effect of intraoperative neuromonitoring of the pelvic autonomous nerves pIONM during surgery. Postoperative urogenital and sexual dysfunction and low anterior syndrome LARS are common complications after TME, affecting patients quality of life, and this research aims to assess whether pIONM can help reduce these issues. Participants will be randomly assigned to one of two groups. The experimental group will receive intraoperative neuromonitoring using a special device that simultaneously monitors sphincter signals and bladder pressure. Electrodes will be placed in the internal and external anal sphincters and surrounding tissues, and bladder manometry will be performed through a catheter connected to a pressure sensor and monitor. Stimulation parameters include a current of 1-25 milliamps at 30 Hz frequency. The control group will undergo TME without intraoperative neuromonitoring. Both open and laparoscopic surgical approaches will be used depending on the case. During the study, participants will undergo assessments before surgery and at multiple postoperative time points, including 3 months and up to 24 months. Evaluations include quality of life questionnaires SF-36, urinary and sexual function questionnaires IIEF, FSFI, IPSS, and tests measuring bladder capacity, compliance, urinary flow, anal sphincter pressure, and anorectal function. Researchers will monitor operative time, bleeding, complications, hospital discharge time, and local cancer recurrence for up to one year. The primary outcome is the change in quality of life three months after surgery.
CONDITIONS
Intraoperative Neuromonitoring of Pelvic Autonomous Nerve Plexus During Total Mesorectal Excision
K
Konstantinos Tepetes, Prof
K
Konstantinos Perivoliotis, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Larissa University Hospital
Lead Sponsor
General Hospital of Larissa
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Surgery day and hospital stay up to 15 days postoperatively
Participants undergo total mesorectal excision (TME) surgery, with or without intraoperative neuromonitoring of the pelvic autonomous nerve plexus. During surgery, special monitoring devices may be used to map nerve function. Immediate post-operative care follows surgery.
1 surgical visit plus hospital stay and assessments until discharge
Duration - Up to 24 months postoperatively
Participants are monitored for recovery and complications after surgery. Follow-up includes assessments of quality of life, urogenital and anorectal function, and other health measures at multiple timepoints up to 24 months after surgery.
Visits at 2, 3, 6, 12, and 24 months postoperatively
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Daniel Dindo, Nicolas Demartines, Pierre-Alain Clavien
https://pubmed.ncbi.nlm.nih.gov/15273542/Werner Kneist, Daniel W Kauff, Roman K Rahimi Nedjat...
https://pubmed.ncbi.nlm.nih.gov/20661601/W Kneist, T Junginger
https://pubmed.ncbi.nlm.nih.gov/15714244/Kyle R Stephenson, Nasreen Toorabally, Leah Lyons...
https://pubmed.ncbi.nlm.nih.gov/26098130/R C Rosen, A Riley, G Wagner...
https://pubmed.ncbi.nlm.nih.gov/9187685/Evelina Pappa, Nick Kontodimopoulos, Dimitris Niakas
https://pubmed.ncbi.nlm.nih.gov/16047519/Charalampos Konstantinidis, Michael Samarinas, Sotirios Andreadakis...
https://pubmed.ncbi.nlm.nih.gov/23221480/MERCURY Study Group
https://pubmed.ncbi.nlm.nih.gov/16984925/D P O'Leary, C J Fide, C Foy...
https://pubmed.ncbi.nlm.nih.gov/11531870/D W Kauff, K P Koch, K H Somerlik...
https://pubmed.ncbi.nlm.nih.gov/21087387/Larissa University Hospital
Lead Sponsor
General Hospital of Larissa
Collaborating Sponsor